Your browser doesn't support javascript.
loading
Mitochondrial complex I inhibition by homoharringtonine: A novel strategy for suppression of chronic myeloid leukemia.
Han, Han; Zhao, Chen; Liu, Mengchen; Zhu, Hongxuan; Meng, Fancheng; Zhang, Ying; Wang, Guibin; Wang, Li; Di, Lijun; Mingyuen Lee, Simon; Zhang, Qingwen; Cui, Guozhen.
Afiliación
  • Han H; School of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, China.
  • Zhao C; State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macau SAR, China.
  • Liu M; School of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, China.
  • Zhu H; School of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, China.
  • Meng F; State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macau SAR, China.
  • Zhang Y; School of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, China.
  • Wang G; State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences, Beijing Institute of Lifeomics, Beijing, China.
  • Wang L; Faculty of Health sciences, University of Macau, Macau SAR, China.
  • Di L; Faculty of Health sciences, University of Macau, Macau SAR, China.
  • Mingyuen Lee S; State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macau SAR, China.
  • Zhang Q; State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macau SAR, China. Electronic address: qwzhang@umac.mo.
  • Cui G; School of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, China. Electronic address: cuigz@zmu.edu.cn.
Biochem Pharmacol ; 218: 115875, 2023 12.
Article en En | MEDLINE | ID: mdl-37871881

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Proteómica Límite: Humans Idioma: En Revista: Biochem Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Proteómica Límite: Humans Idioma: En Revista: Biochem Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido